{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:58:16Z","timestamp":1790873896125,"version":"4.1.0"},"reference-count":42,"publisher":"EDP Sciences","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1051\/medsci\/2006224437","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T12:24:13Z","timestamp":1299327853000},"page":"437-443","source":"Crossref","is-referenced-by-count":8,"title":["Terutroban et r\u00e9cepteurs TP endoth\u00e9liaux dans l\u2019ath\u00e9rogen\u00e8se"],"prefix":"10.1051","volume":"22","author":[{"given":"Tony J.","family":"Verbeuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2006,4,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Hamberg M, Svennsson J, Samuelson B. Thromboxanes : a new group of biologically active compounds derived from prostaglandin endoperoxides.Proc Natl Acad Sci USA1975; 72 : 2994\u20138.","DOI":"10.1073\/pnas.72.8.2994"},{"key":"R2","unstructured":"Vane JR, Flower R, Botting RM. The mechanism of action of aspirin. In : Vane JR, Botting RM, eds.Aspirin and other salicylates. London : Chapman and Hall Medical, 1992 : 35\u201359."},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Awtry EH, Loscalzo J. Aspirin.Circulation2000; 101 : 1206\u201318.","DOI":"10.1161\/01.CIR.101.10.1206"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors : structures, properties, and functions.Physiol Rev1999; 79 : 1193\u2013226.","DOI":"10.1152\/physrev.1999.79.4.1193"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Halushka PV. Thromboxane A2receptors : where have you gone ?Prostagl Lipid Med2000; 60 : 175\u201389.","DOI":"10.1016\/S0090-6980(99)00062-3"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Hirata M, Ushikubi F, Kakizuka A,et al.Two thromboxane A2receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivities to Arg60 to Leu mutation.J Clin Invest1996; 97 : 949\u201356.","DOI":"10.1172\/JCI118518"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Kinsella BT. Thromboxane A2signalling in humans : a \"tail\" of two receptors.Biochem Soc Trans2001 : 29 : 641\u201354.","DOI":"10.1042\/bst0290641"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Hall SE. Thromboxane A2receptor antagonists.Med Res Rev1991; 11 : 503\u201379.","DOI":"10.1002\/med.2610110504"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Dogn\u00e9 JM, Hanson J, de Leval X,et al.New developments on thromboxane modulators.Mini Rev Med Chem2004; 4 : 649\u201357.","DOI":"10.2174\/1389557043403684"},{"key":"R10","unstructured":"Verbeuren TJ, Simonet S, Descombes JJ,et al.S 18204 : a new powerful TXA2-receptor antagonist with a long duration of action.Thromb Haemost1995; 73 : 1324."},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Cimeti\u00e8re B, Dubuffet T, Muller O,et al.Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists.Bioorg Med Chem Lett1998; 8 : 1375\u201380.","DOI":"10.1016\/S0960-894X(98)00220-0"},{"key":"R12","unstructured":"Verbeuren TJ, Vallez MO, Petit C,et al.Amelioration of albuminuria in the diabetic rat by S 18204, an anti-thromboxane receptor antagonist.Circulation1995; 92 : 222."},{"key":"R13","unstructured":"Simonet S, Descombes JJ, Vallez MO,et al.S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig. In : Sinzinger Het al., eds.Recent advances in prostaglandin, thromboxane and leukotriene research.New York : Plenum Press, 1998 : 173\u20136."},{"key":"R14","unstructured":"Vallez MO, Rupin A, De Nanteuil G, Verbeuren T. Synergistic antithrombotic effects of the TP-receptor antagonist S 18886 and the direct thrombin inhibitor S 31307 in a thrombosis model of the rat abdominal aorta.Thromb Haemost2001; P1625."},{"key":"R15","unstructured":"Verbeuren T, Descombes JJ, Simonet S,et al.The TP-receptor antagonist S 18886 unmasks vascular relaxation and potentiates the anti-platelet action of PGD2.Thromb Haemost1997; 693."},{"key":"R16","unstructured":"Descombes JJ, Menant Y, Lavielle G, Verbeuren TJ. Binding properties of a potent, long acting new thromboxane receptor antagonist, [3H] S 18886, on human, rat and dog platelet membranes.Br J Pharmacol1997; 122 : 381P."},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Gaussem P, R\u00e9ny JL, Thalamas C,et al.The specific thromboxane receptor antagonist S 18886 : pharmacokinetic and pharmacodynamic studies.J Thromb Haemost2005; 3 : 1437\u201345.","DOI":"10.1111\/j.1538-7836.2005.01468.x"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Belhassen L, Pelle G, Dubois-Rande JL, Adnot S. Improved endothelial function by the thromboxane A2receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin.J Am Coll Cardiol2003; 41 : 1198\u2013204.","DOI":"10.1016\/S0735-1097(03)00048-2"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Taddei S, Virdis A, Ghiadoni L,et al.Endothelial dysfunction in hypertension.J Cardiovasc Pharmacol2001; 38 : S11\u20134.","DOI":"10.1097\/00005344-200111002-00004"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Yang D, F\u00e9l\u00e9tou M, Levens N,et al.A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR.Hypertension2003; 41 : 143\u20138.","DOI":"10.1161\/01.HYP.0000047651.45322.16"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Maalej N, Osman HE, Shanmuganayagam D,et al.Antithrombotic properties of the thromboxane A2\/prostaglandin H2receptor antagonist S18886 on prevention of platelet-dependent cyclic flow reductions in dogs.J Cardiovasc Pharmacol2005; 45 : 389\u201395.","DOI":"10.1097\/01.fjc.0000157439.49612.83"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Osende JI, Shimbo D, Fuster V,et al.Antithrombotic effects of S 18886, a novel orally active thromboxane A2receptor antagonist.J Thromb Haemost2004; 2 : 492\u20138.","DOI":"10.1111\/j.1538-7933.2004.00639.x"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Verbeuren TJ, Jordaens FH, Zonnekeyn LL,et al.Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits.Circ Res1986; 58 : 552\u201364.","DOI":"10.1161\/01.RES.58.4.552"},{"key":"R24","unstructured":"Verbeuren TJ. Endothelium and coronary atherosclerosis, an update.Coronary Artery Disease1993; num\u00e9ro sp\u00e9cial : 72\u201387."},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Cayatte AJ, Du Y, Oliver-Krasinski J,et al.The thromboxane-receptor antagonist, S 18886 but not aspirin inhibits atherogenesis in apolipoprotein E deficient mice : evidence that eicosanoids other than thromboxane contribute to atherosclerosis.Arterioscler Thromb Vasc Biol2000; 20 : 1724\u20138.","DOI":"10.1161\/01.ATV.20.7.1724"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Osborne JA, Lefer AM. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.Am J Physiol1988; 255 : H318\u201324.","DOI":"10.1152\/ajpheart.1988.255.2.H318"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Van Diest M, Herman AG, Verbeuren TJ. Influence of hypercholesterolemia on the reactivity of isolated rabbit arteries to 15-lipoxygenase metabolites of arachidonic acid : comparison with platelet-derived agents and vasodilators.Prostaglandins Leukot Essent Fatty Acids1996; 54 : 135\u201345.","DOI":"10.1016\/S0952-3278(96)90071-X"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Montuschi P, Barnes PJ, Roberts LJII. Isoprostanes : markers and mediators of oxidative stress.FASEB J2004; 18 : 1791\u2013800.","DOI":"10.1096\/fj.04-2330rev"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Ishizuka T, Suzuki K, Kawakami M,et al.Thromboxane A2receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.Eur J Pharmacol1996; 312 : 367\u201377.","DOI":"10.1016\/0014-2999(96)00478-5"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Tahara Y, Matsumoto M,et al.Roles of thromboxane A2and prostacyclin in the development of atherosclerosis in apoE-deficient mice.J Clin Invest2004; 114 : 784\u201394.","DOI":"10.1172\/JCI21446"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Zuccollo A, Shi C, Mastroani R,et al.The thromboxane A2receptor antagonist, S 18886, prevents enhanced atherogenesis caused by diabetes mellitus.Circulation2005; 112 : 3001\u20138.","DOI":"10.1161\/CIRCULATIONAHA.105.581892"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Ishizuka T, Matsui T, Kurita A. Ramatroban, a TP receptor antagonist, improves vascular responses to acetylcholine in hypercholesterolemic rabbitsin vivo.Eur J Pharmacol2003; 468 : 27\u201335.","DOI":"10.1016\/S0014-2999(03)01626-1"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Egan KM, Wang M, Lucitt MB,et al.Cyclooxygenases, thromboxane, and atherosclerosis : plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.Circulation2005; 111 : 334\u201342.","DOI":"10.1161\/01.CIR.0000153386.95356.78"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Cheng Y, Austin SC, Rocca B,et al.Role of prostacyclin in the cardiovascular response to thromboxane A2.Science2002; 296 : 539\u201341.","DOI":"10.1126\/science.1068711"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Worth NF, Berry CL, Thomas AC, Campbell JH. S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits.Atherosclerosis2005; 183 : 65\u201373.","DOI":"10.1016\/j.atherosclerosis.2005.02.034"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Viles-Gonzalez JF, Fuster V, Corti R,et al.Atherosclerosis regression and TP receptor inhibition : effect of S 18886 on plaque size and composition. A magnetic resonance imaging study.Eur Heart J2005; 26 : 1557\u201361.","DOI":"10.1093\/eurheartj\/ehi175"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Xu S, Maitland KA, Jiang B,et al.The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic Apo E-deficient mice.Diabetes2006; 55 : 110\u20139.","DOI":"10.2337\/diabetes.55.1.110"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Simmons TR, Cook JA, Moore JN, Halushka PV. Thromboxane A2receptors in equine monocytes : identification of a new subclass of TXA2receptors.J Leukoc Biol1993; 53 : 173\u20138.","DOI":"10.1002\/jlb.53.2.173"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Nagata T, Uehara Y, Numabe A,et al.Regulatory effect of thromboxane A2on proliferation of vascular smooth muscle cells from rats.Am J Physiol1992; 263 : H1331\u20138.","DOI":"10.1152\/ajpheart.1992.263.5.H1331"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Gao Y, Yokota R, Tang S,et al.Reversal of angiogenesisin vitro, induction of apoptosis, and inhibition of Akt phosphorylation in endothelial cells by thromboxane A2.Circ Res2000; 87 : 739\u201345.","DOI":"10.1161\/01.RES.87.9.739"},{"key":"R41","unstructured":"Verbeuren TJ, Cohen RA. Role of TP-receptors in atherosclerosis and vascular endothelial dysfunction. In : Abstracts of theSymposium on endothelial factors and coronary disease. Hong Kong, China, 2004 : 22 (abstract)."},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Tang M, Cyrus T, Yao Y,et al.Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2a-III. Evidence from apolipoprotein E- and LDL receptor-deficient mice.Circulation2005; 112 : 2867\u201374.","DOI":"10.1161\/CIRCULATIONAHA105.562223"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2006224437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:13:03Z","timestamp":1637356383000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2006224437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":42,"journal-issue":{"issue":"4"},"alternative-id":["medsci2006224p437"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2006224437","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}